Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Act 2024 (50 of 2024)

Schedule 4   Supply of therapeutic vaping goods by pharmacists without prescription

Part 1   Amendments

Therapeutic Goods (Poisons Standard - June 2024) Instrument 2024

13   In the appropriate position in Schedule 3

Insert:

NICOTINE in therapeutic vaping goods (within the meaning of the Therapeutic Goods Regulations 1990) in final dosage form for smoking cessation or the management of nicotine dependence when:

(a) for supply to persons aged 18 years and over; and

(b) the pharmacist requests and sights evidence of the patient's identity and age; and

(c) the pharmacist provides professional advice to the patient on alternative cessation supports and therapies, appropriate dose and frequency depending on age, weight and severity of condition, length of treatment, suitable titration, and interactions with other medicines; and

(d) the pharmacist provides contact details about smoking cessation support services to the patient; and

(e) the quantity of the goods does not exceed the quantity that is reasonably required for a patient's therapeutic use for 1 month and that quantity is supplied to the patient only once in a month; and

(f) the concentration of nicotine in the goods does not exceed 20 mg/mL; and

except :

(g) in preparations for oromucosal or transdermal administration for human therapeutic use when included in the Register as an aid in withdrawal either from tobacco smoking or nicotine vaping; or

(h) in tobacco prepared and packed for smoking.